JS on Smart Investor (video interview), page-44

First 44 Last

Share
Profile

Follow
wewill

365 Posts.

70

15/03/18

10:35

Post #: 31769920
Share

Originally posted by BeerBaron ↑

With the greatest respect, I think you are mis-characterising what went on here.

The spike in shorts was extraordinary, way above day to day short levels. And the spikes occurred one or a few days before each ASX article. There were zero other occasions with dramatic spikes in short positions.

You said: "If someone takes a short position because they’ve uncovered info relating to the company that they think will be damaging, there’s nothing wrong with that" - is not sufficient. There are two possibilities where this could be illegal:

(1) If that someone has information that is not available to anyone else in the market, it is insider information and it is illegal to act upon it.

(2) If that someone uses that information to conduct a sensational media campaign with the sole purpose of scaremongering and driving down the share price, that is market manipulation and is not legal.

I think there are strong grounds to consider the possibility of (1) or (2) or both. I make no claim as to who was involved.

What occurred was completely different to someone taking out a few short positions on a day to day basis. It was clearly co-ordinated with the release of AFR articles and occurred before they were printed, which infers some pre-knowledge of events that was not available to the market.

Expand

Not looking to fuel any fire but I am curious. My question is this. Hypothetically if there was a conspiracy and it could be proven - how would that help shareholders? What recourse is available and if so against whom?

I would think AFR legal will have covered all their tracks and I cannot see them putting JS in the spotlight if they thought there was something untoward that could pop up.

Just my opinion.

BIG Price at posting: $2.22 Sentiment: Hold Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

ZNC

Zenith's sale of Develin Creek delivers $975K cash, with shares up 13%

The iron ore comeback: Can it last?

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

HAS

Hastings progressing Yangibana to production with lower costs